Therapy sought to reduce major risk from minor bleeding that can follow stroke

May 12, 2014, Medical College of Georgia
This is Dr. Adviye Ergul, vascular physiologist at the Medical College of Georgia at Georgia Regents University. Credit: Phil Jones

Bleeding into the brain following a stroke doesn't have to be big to be bad, says a researcher exploring a therapy to eliminate the major risk of minor bleeding.

The main problem with a minor bleed is the Iron in the blood , which is essential to transporting oxygen to the brain and body, but can be lethal when it comes in direct contact with brain tissue, said Dr. Adviye Ergul, vascular physiologist at the Medical College of Georgia at Georgia Regents University.

"We need iron in our blood, but we don't want it in our brain," said Ergul, who recently received a $1.8 million grant from the National Institutes of Health to better understand how a relatively small amount of blood and iron are bad for the brain and whether an agent that mops up iron can help.

Her focus is diabetes, which puts patients at higher risk of , , and poor recovery. As with the general population, people with diabetes are at greatest risk for a clot-based stroke that interrupts blood and oxygen supplies to the brain, much as a heart attack does to the heart.

But the damage diabetes does to – making existing vessels leaky and prompting proliferation of new, leaky ones – also means these patients may subsequently experience bleeding from the miles of tiny blood vessels in their brain.

"Patients with diabetes are more likely to bleed into the brain following an ischemic stroke," Ergul said. "It happens spontaneously; it also happens with tPA." Tissue plasminogen activator, or tPA, is a clot-busting agent and the only currently approved medical therapy for stroke. Bleeding is a known risk of tPA that increases in diabetes.

"Patients with diabetes are some of the highest risk patients to bleed with tPA," Ergul said. In fact, while no such recommendations exists in the United States, in Europe, patients with prior stroke and diabetes are not given tPA when they have a recurrent stroke.

From observations in her animal models as well as humans, Ergul suspects many patients with diabetes who have a stroke likely could benefit from rapid removal of iron from the brain.

She is looking at the iron chelating agent, deferoxamine, which basically binds to iron so it becomes inactive and can be easily eliminated in the urine. Deferoxamine, already used clinically for iron overdoses and certain anemias, is under study for hemorrhagic stroke treatment. Hemorrhagic strokes, which are far less common than clot-based strokes and typically more lethal, result from major bleeding from some of the larger arteries in the brain. The rapid, resulting destruction is caused by a large amount of blood pushing brain tissue aside and up again the skull.

While the bleeding that follows a clot-based stroke likely doesn't produce sufficient volume to put that kind of pressure on the brain, the comparatively small amount of bleeding that occurs still exposes brain cells to iron.

"Iron not only kills neurons, we think it also kills in the brain and it affects how endothelial cells can repair themselves." Ergul said. Endothelial cells, which line all blood vessels, comprise the majority of the tiny capillaries which have only one layer of contractile cells on top. Larger vessels have multiple layers of smooth muscle cells.

Similar to what happens with aging, the tiny vessels don't relax or regenerate normally in diabetes. Ergul has evidence that iron, which shouldn't be in , also stimulates inflammation as part of an immune response, which further increases the leakiness of the capillaries.

While attempts to stop bleeding in a hemorrhagic stroke are often unsuccessful, essentially nothing is done for bleeding following a clot-based stroke, Ergul said. In fact, clinicians may view the bleeding as an indicator that blood flow has been reestablished to the struggling tissue.

In her stroke models, she is using the chelation agent daily for two weeks alone or after administering tPA, to see how the drugs interact and look at levels of recovery. Within 14 days, normal animals would have mostly recovered from the stroke. She's also examining further how stroke recovery is impacted by diabetes.

While new blood vessels are a good thing in the heart or legs, "We are making the argument that making new blood vessels is not always a good thing," Ergul said. "We need to find ways to stimulate stable and functional new vessels." Ergul notes that the abnormal blood vessel proliferation that occurs in the brain is very similar to the sight-destroying vessels that proliferate in the eye in diabetic retinopathy.

More than 7 percent of Americans have which puts them at a two- to six-fold increased risk of an ischemic, or clot-based, stroke and poor recovery. Arteries feed arterioles which feed the 400 miles of capillaries in the , which feed back into the venous system.

Explore further: Stroke risk reduced if brain blood vessel disorder is left alone

Related Stories

Stroke risk reduced if brain blood vessel disorder is left alone

April 29, 2014
Treating patients who suffer from a common condition that affects blood vessels in the brain increases their risk of stroke, a study has found.

Artery-clearing surgery after stroke should be delayed

February 26, 2014
Treating stroke is a race against time. To prevent brain damage and save lives, physicians have to diagnose and treat strokes as quickly as possible. Now, a new study suggests doctors can reduce risks by delaying a commonly ...

Study IDs new cause of brain bleeding immediately after stroke

April 17, 2014
By discovering a new mechanism that allows blood to enter the brain immediately after a stroke, researchers at UC Irvine and the Salk Institute have opened the door to new therapies that may limit or prevent stroke-induced ...

Clot-busting drug safe for stroke patients taking blood thinner

May 10, 2012
Acute ischemic stroke patients taking the blood thinner warfarin can be treated safely with the clot-busting drug tissue plasminogen activator (tPA), according to research presented at the American Heart Association's Quality ...

Substance naturally found in humans is effective in fighting brain damage from stroke

March 11, 2014
A molecular substance that occurs naturally in humans and rats was found to "substantially reduce" brain damage after an acute stroke and contribute to a better recovery, according to a newly released animal study by researchers ...

Recommended for you

Biomechanical mapping method aids development of therapies for damaged heart tissue

January 23, 2018
Researchers have developed a new way to capture the detailed biomechanical properties of heart tissue. The high-resolution optical technique fills an important technology gap necessary to develop and test therapies that might ...

Researchers borrow from AIDS playbook to tackle rheumatic heart disease

January 22, 2018
Billions of US taxpayer dollars have been invested in Africa over the past 15 years to improve care for millions suffering from the HIV/AIDS epidemic; yet health systems on the continent continue to struggle. What if the ...

A nanoparticle inhalant for treating heart disease

January 18, 2018
A team of researchers from Italy and Germany has developed a nanoparticle inhalant for treating people suffering from heart disease. In their paper published in the journal Science Translational Medicine, the group describes ...

Starting periods before age of 12 linked to heightened risk of heart disease and stroke

January 15, 2018
Starting periods early—before the age of 12—is linked to a heightened risk of heart disease and stroke in later life, suggests an analysis of data from the UK Biobank study, published online in the journal Heart.

'Decorated' stem cells could offer targeted heart repair

January 10, 2018
Although cardiac stem cell therapy is a promising treatment for heart attack patients, directing the cells to the site of an injury - and getting them to stay there - remains challenging. In a new pilot study using an animal ...

Exercise is good for the heart, high blood pressure is bad—researchers find out why

January 10, 2018
When the heart is put under stress during exercise, it is considered healthy. Yet stress due to high blood pressure is bad for the heart. Why? And is this always the case? Researchers of the German Centre for Cardiovascular ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.